Anthony Martin, DO

Review
Review
Drug-Induced Spruelike Enteropathy: What Clinicians Need to Know About Olmesartan
10/31/2016
Fantley C. Smither, MD; Laurel Fick, MD; Evan West, MD; Kapil Mehta, MD; Anthony Martin, DO; Wesley Prichard, DO
The constellation of chronic diarrhea, abdominal pain, weight loss, and malnutrition accompanied with biopsy-proven villous atrophy and/or an elevated tissue transglutaminase antibody level usually leads to...
10/31/2016
Review
Review
Drug-Induced Spruelike Enteropathy: What Clinicians Need to Know About Olmesartan
10/31/2016
Fantley C. Smither, MD; Laurel Fick, MD; Evan West, MD; Kapil Mehta, MD; Anthony Martin, DO; Wesley Prichard, DO
The constellation of chronic diarrhea, abdominal pain, weight loss, and malnutrition accompanied with biopsy-proven villous atrophy and/or an elevated tissue transglutaminase antibody level usually leads to...
10/31/2016
Review
Review
Drug-Induced Spruelike Enteropathy: What Clinicians Need to Know About Olmesartan
10/31/2016
Fantley C. Smither, MD; Laurel Fick, MD; Evan West, MD; Kapil Mehta, MD; Anthony Martin, DO; Wesley Prichard, DO
The constellation of chronic diarrhea, abdominal pain, weight loss, and malnutrition accompanied with biopsy-proven villous atrophy and/or an elevated tissue transglutaminase antibody level usually leads to...
10/31/2016
Review
Review
Drug-Induced Spruelike Enteropathy: What Clinicians Need to Know About Olmesartan
10/31/2016
Fantley C. Smither, MD; Laurel Fick, MD; Evan West, MD; Kapil Mehta, MD; Anthony Martin, DO; Wesley Prichard, DO
The constellation of chronic diarrhea, abdominal pain, weight loss, and malnutrition accompanied with biopsy-proven villous atrophy and/or an elevated tissue transglutaminase antibody level usually leads to...
10/31/2016
Review
Review
Drug-Induced Spruelike Enteropathy: What Clinicians Need to Know About Olmesartan
10/31/2016
Fantley C. Smither, MD; Laurel Fick, MD; Evan West, MD; Kapil Mehta, MD; Anthony Martin, DO; Wesley Prichard, DO
The constellation of chronic diarrhea, abdominal pain, weight loss, and malnutrition accompanied with biopsy-proven villous atrophy and/or an elevated tissue transglutaminase antibody level usually leads to...
10/31/2016
Review
Review
Drug-Induced Spruelike Enteropathy: What Clinicians Need to Know About Olmesartan
10/31/2016
Fantley C. Smither, MD; Laurel Fick, MD; Evan West, MD; Kapil Mehta, MD; Anthony Martin, DO; Wesley Prichard, DO
The constellation of chronic diarrhea, abdominal pain, weight loss, and malnutrition accompanied with biopsy-proven villous atrophy and/or an elevated tissue transglutaminase antibody level usually leads to...
10/31/2016